Medicare Will Only Cover New Alzheimer’s Drug in Trials
April 8, 2022 — Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer’s drug aducanumab (Aduhelm) if the patients are participating in clinical trials. On Thursday, the Centers for Medicare & Medicaid Services (CMS) released its national coverage determination for aducanumab and other similar drugs that … Read more